Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Shefta E. Moula"'
Autor:
Arun Sankaradoss, Suraj Jagtap, Junaid Nazir, Shefta E. Moula, Ayan Modak, Joshuah Fialho, Meenakshi Iyer, Jayanthi S. Shastri, Mary Dias, Ravisekhar Gadepalli, Alisha Aggarwal, Manoj Vedpathak, Sachee Agrawal, Awadhesh Pandit, Amul Nisheetha, Anuj Kumar, Mahasweta Bordoloi, Mohamed Shafi, Bhagyashree Shelar, Swathi S. Balachandra, Tina Damodar, Moses Muia Masika, Patrick Mwaura, Omu Anzala, Kar Muthumani, Ramanathan Sowdhamini, Guruprasad R. Medigeshi, Rahul Roy, Chitra Pattabiraman, Sudhir Krishna, Easwaran Sreekumar
Publikováno v:
Molecular Therapy
The ongoing COVID-19 pandemic highlights the need to tackle viral variants, expand the number of antigens, and assess diverse delivery systems for vaccines against emerging viruses. In the present study, a DNA vaccine candidate was generated by combi
Autor:
Sachee Agrawal, Moses Masika, Manoj Vedpathak, Anuj Kumar, Patrick Mwaura, Ravisekhar Gadepalli, Swathi Balachandra, Amul Nisheetha, Rahul Roy, Chitra Pattabiraman, Mary Dias, Jayanthi Shastri, Sudhir Krishna, Guruprasad R. Medigeshi, Mohamed Shafi, Arun Sankaradoss, E. Sreekumar, Ramanathan Sowdhamini, Ayan Modak, Meenakshi S Iyer, Tina Damodar, Alisha Aggarwal, Omu Anzala, Karuppiah Muthumani, Junaid Nazir, Awadhesh Pandit, Joshuah Fialho, Suraj Jagtap, Shefta E-Moula
Following the recent clinical clearance of an Indian DNA COVID-19 vaccine, India and Africa are potential regions where DNA vaccines may become a major delivery system subject to a range of immunological and regulatory scrutiny. The ongoing COVID pan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::652e5a9a07509fadc8d8b53711382102
https://doi.org/10.1101/2021.09.21.21263883
https://doi.org/10.1101/2021.09.21.21263883